Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (1452)	2/20/1998 3:30:00 AM
From: Ryan Weisman	Respond to of 1894

Sig, let's hope that they are selling product, and shipping it, and collecting money and all that good stuff. That is why we all bought the stock. The NASDAQ BB thing is confusing, but if the company starts to show revenue and continued sales growth, I would assume the companies value will begin to come to light (and the management/IR incompetency will be brushed under the carpet). Not every co. is being run by Michael Dell, and not every company is at the head of a multi-billion dollar industry. (The former ACMIC(!) isn't, the latter it is.) Just trying to remain optimistic, RYAN

To: Sigmund who wrote (1452)	2/20/1998 9:00:00 AM
From: Cisco	Read Replies (1) \| Respond to of 1894

Sigmund, The $500,000 shortfall is what is required to maintain the $4 million net required for the National NASDAQ. I believe the Small Cap NASDAQ requires only $2 million net or market cap of $35 million along with a $1 min. bid price to retain listing. However to be initially listed to the Small Cap NASDAQ requires $4 million net or $50 million market cap with min. bid of $4. The key question that we do not have the answer to is what are the conditions that NASDAQ is requiring AccuMed to meet in order to be excepted from the initial listing requirement to the Small Cap NASDAQ? If they meet these requirements, they should easily be able to retain their listing until they have the earnings to return to the National NASDAQ. I believe the shareholders have a right to know what the conditions are!!! If anyone talks to AccuMed today, please ask them that question. When AccuMed states in a public release that they expect to meet a target that is only 30 days away, I assume they know what they are talking about. If they don't then I agree with Sigmund that the management has been incompetent. I am betting that AccuMed will meet the conditions of NASDAQ. AccuMed and its market makers know that the bid has to be at least $1. That's why I am buying at these levels. If I am wrong and AccuMed drops to the BB level, then I am stuck for awhile. To get back my investment I will have to wait until the company turns profitable later this year. If 4th quarter earnings are just so so, perhaps it would be best for AccuMed not to release them until after they solve the NASDAQ question which I believe will be decided one way or the other by March 20th. This would especially be true if 1st quarter numbers are much better and are scheduled to come out in April. If 4th quarter numbers are positive they will probably come out next week. For the time being I am committed and it doesn't do me any good to worry. The company is not delisted yet as some have seemed to conclude. Cisco